In wake of disease claim warning, Life Extension said it will tweak page layouts but won’t back down from core mission

By Hank Schultz contact

- Last updated on GMT

iStock
iStock
Despite receiving a warning letter from the Food and Drug Administration about disease claims on its website, supplement manufacturer Life Extension said it is not going to change its basic mode of communication with its customers.

This will not change who we are. We are an information based company,​ said Dr Michael A. Smith MD, senior health scientist for Florida-based Life Extension.

Our basic statement is that we are investigating this and we are confident that we are in full compliance with federal regulations,​ Dr Smith told NutraIngredients-USA.

FDA: Products promoted as disease treatments

In the letter FDA objected to the way that Life Extension was disseminating health information. The company has many pages on its website devoted to different diseases, with sections of these pages called “Health Protocols” devoted to treatment modalities. According to FDA the company was presenting its products via these protocols as treatments for these diseases. For example, the agency noted under the disease, Breast Cancer you include a link to a page with information about breast cancer and include, Life Extensions Suggestions which lists products and directions for use as part of the protocol.​ There followed a list of more than 30 Life Extension products suggested as being helpful for breast cancer sufferers.

FDA noted that Life Extension has more than 80 such disease-oriented sections on its website, each with its own product-recommendation section.  The agency also noted that the the company had been making disease claims via Facebook postings, including a case where a Life Extension product was promoted for its ability to prevent blindness.  The agency alleged that disease claim language was interwoven throughout the company’s marketing of its products.

We note that there are over 400 products on your website that contain various disease claims. You should review your website for violations not mentioned in this letter,​ the agency wrote.

Discussion of disease still a prominent feature

Dr. Smith said that in his company’s view, the issue was a too-close relationship between Life Extension products and the information the company disseminates about the various diseases.

This was about FDA questioning the layout of certain pages. There really wasnt anything to this except where we were placing some links a little too close to that information,​ he said. Dr Smith said those pages are being revised to remove the close links to where readers of the information can purchase the products in question. But he said Life Extension won’t back down when it comes to talking about the role of nutrition in health and in the prevention of disease. The breast cancer pages on the company’s website, for example, still include lengthy discussions about the role of certain ingredients, such as curcumin.  Life Extension will continue to sell products containing those ingredients, Dr Smith said.

This ​(the warning letter) has nothing to do with how we will continue to write articles and protocols. We will continue to disseminate information about cancer, Alzheimers disease and other conditions.  Those protocol pages dont link in any way to product suggestions,” ​he said.

Related news

Show more

Related products

show more

Gemini Pharmaceuticals Quality Partnership Program

Gemini Pharmaceuticals Quality Partnership Program

Gemini Pharmaceuticals | 09-Oct-2017 | Technical / White Paper

A Brand Owner/Own Label Distributor is 100% responsible for the quality of their products - not the Contract Manufacturing Organization. This is exactly...

Resveratrol – Revitalizing Cognitive Function

Resveratrol – Revitalizing Cognitive Function

Evolva | 29-Sep-2017 | Technical / White Paper

Cognitive decline is fast becoming the biggest concern of the 65+ population. A population which is set to reach 1.1 billion by 2030*.  · 80% of 60+ take...

Natural, slow-release caffeine by Lipofoods

Natural, slow-release caffeine by Lipofoods

Lipofoods, a Lubrizol Company | 25-Sep-2017 | Data Sheet

Lipofoods presents NEWCAFF™ microcapsules, a natural, slow-release caffeine with a clean non-bitter taste, ideal for sports and nutrition products targeting...

Related suppliers

1 comment

How sad...

Posted by Martin Wolff,

Too bad the FDA doesn't do some research on it's own regarding supplements and improved health, and sharing it with the 'folks'. Instead the FDA is in bed with the pharmaceutical industry and automatically attacks any other industry's efforts to help the public with "alternative" remedies, and that's unfortunate.

Report abuse

Follow us

Products

View more

Webinars